Viralgen and Elaaj Bio Join Forces to Enhance CDKL5 Gene Therapy Research#Spain#San_Sebastián#Viralgen#Elaaj_Bio#CDKL5_Disorder
Viralgen and Elaaj Bio Join Forces to Enhance CDKL5 Gene Therapy Research
In a remarkable collaboration, Viralgen partners with Elaaj Bio to expedite gene therapy solutions for CDKL5 Deficiency Disorder, targeting critical needs in rare pediatric care.
third-news.com
May 5, 2026 at 1:29 PM
Viralgen and Elaaj Bio Join Forces to Enhance CDKL5 Gene Therapy Research#Spain#San_Sebastián#Viralgen#Elaaj_Bio#CDKL5_Disorder
Advancing Gene Therapy: Viralgen and Elaaj Bio Team Up for CDKL5 Disorder#USA#San_Sebastián#Viralgen#Elaaj_Bio#CDKL5_Disorder
Advancing Gene Therapy: Viralgen and Elaaj Bio Team Up for CDKL5 Disorder
Viralgen collaborates with Elaaj Bio to push forward a pioneering gene therapy program for CDKL5 Deficiency Disorder, aiming for clinical development.
third-news.com
May 5, 2026 at 1:36 PM
Advancing Gene Therapy: Viralgen and Elaaj Bio Team Up for CDKL5 Disorder#USA#San_Sebastián#Viralgen#Elaaj_Bio#CDKL5_Disorder